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ABSTRACT Recent Zika virus (ZIKV) infections have been associated with a range of
neurological complications, in particular congenital microcephaly. Human neural pro-
genitor cells (hNPCs) are thought to play an important role in the pathogenesis of
microcephaly, and experimental ZIKV infection of hNPCs has been shown to induce
cell death. However, the infection efﬁciency and rate of cell death have varied be-
tween studies, which might be related to intrinsic differences between African and
Asian lineage ZIKV strains. Therefore, we determined the replication kinetics, includ-
ing infection efﬁciency, burst size, and ability to induce cell death, of two Asian and
two African ZIKV strains. African ZIKV strains replicated to higher titers in Vero cells,
human glioblastoma (U87MG) cells, human neuroblastoma (SK-N-SH) cells, and
hNPCs than Asian ZIKV strains. Furthermore, infection with Asian ZIKV strains did not
result in signiﬁcant cell death early after infection, whereas infection with African
ZIKV strains resulted in high percentages of cell death in hNPCs. The differences be-
tween African and Asian lineage ZIKV strains highlight the importance of including
relevant ZIKV strains to study the pathogenesis of congenital microcephaly and cau-
tion against extrapolation of experimental data obtained using historical African
ZIKV strains to the current outbreak. Finally, the fact that Asian ZIKV strains infect
only a minority of cells with a relatively low burst size together with the lack of
early cell death induction might contribute to its ability to cause chronic infections
within the central nervous system (CNS).
IMPORTANCE The mechanism by which ZIKV causes a range of neurological compli-
cations, especially congenital microcephaly, is not well understood. The fact that
congenital microcephaly is associated with Asian lineage ZIKV strains raises the question
of why this was not discovered earlier. One possible explanation is that Asian and Afri-
can ZIKV strains differ in their abilities to infect cells of the CNS and to cause neurode-
velopmental problems. Here, we show that Asian ZIKV strains infect and induce cell
death in human neural progenitor cells—which are important target cells in the devel-
opment of congenital microcephaly—less efﬁciently than African ZIKV strains. These fea-
tures of Asian ZIKV strains likely contribute to their ability to cause chronic infections, of-
ten observed in congenital microcephaly cases. It is therefore likely that phenotypic
differences between ZIKV strains could be, at least in part, responsible for the ability of
Asian ZIKV strains to cause congenital microcephaly.
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Since the emergence of Zika virus (ZIKV) in 2015 in South America, infections havecaused a wide spectrum of neurological diseases, such as Guillain-Barré syndrome,
myelitis, meningoencephalitis, and in particular congenital microcephaly (1). Even
though ZIKV was ﬁrst detected in Uganda in 1947 in a rhesus monkey and has caused
repeated outbreaks since 2007, not much was known about the pathogenesis of
disease caused by ZIKV before the 2015 outbreak. Since then, several studies have
shown that ZIKV can infect a variety of neuronal cells, but more insight into the
pathogenesis of ZIKV-induced central nervous system (CNS) diseases is needed (2).
An important question that remains is whether the emergence of ZIKV in South
America and the associated clinical ﬁndings are the result of genetic and phenotypic
changes in the emerging ZIKV strain or whether they can be attributed to the
introduction of ZIKV in a large naive population (3). Phylogenetically, two distinct
lineages of ZIKV exist: the African lineage and the Asian lineage (4). The current
outbreak strain belongs to the Asian lineage, and sequence analysis revealed that the
virus has changed signiﬁcantly over the last 50 years, both in nucleotide sequences and
amino acid composition (4, 5). The prototype ancestral ZIKV strain, MR766, of the
African lineage has been used in many initial studies (6–9), but recent in vitro and in vivo
studies have shown some differences between African and Asian ZIKV strains (10–14).
Whether there are also phenotypic differences between Asian ZIKV strains, caused by
amino acid substitutions acquired just before the outbreak in South America, is
currently unknown (5).
ZIKV has been shown to replicate and induce cell death in neuronal cells of fetal
mice (5, 15), as well as in human neural progenitor cells and brain organoids (6, 7, 11,
12), a mechanism thought to play an important role in the pathogenesis of ZIKV-
induced microcephaly. A recent study has shown that an African ZIKV strain might be
able to infect human neural stem cells (hNSCs) and astrocytes more efﬁciently than
Asian ZIKV strains (12). However, a comprehensive study on the replication kinetics and
the ability to cause cell death of different African and Asian ZIKV strains is currently
lacking (2).
To be able to detect phenotypic differences between Asian and African ZIKV strains
or between recent Asian ZIKV strains, it is important to characterize and understand the
in vitro replication kinetics—including the infection efﬁciency, burst size, and ability to
cause cell death—of these viruses. Therefore, we determined the replication kinetics of
two Asian ZIKV strains (isolated in 2013 and 2016) and two African ZIKV strains (isolated
in 1947 and 1961) on induced pluripotent stem cell-derived human neural progenitor
cells (hNPCs) and several human neural cell lines.
RESULTS
Phylogenetic and amino acid variance analysis of ZIKV strains selected in this
study. Four ZIKV strains were included in this study (Fig. 1A). Two African strains, ZIKV
MR766 (ZIKVAF-MR766) and Uganda 976 (ZIKVAF-976), were isolated in 1947 and 1961,
respectively, and passaged on mouse brain tissue and Vero cells. The two Asian ZIKV
strains included were H/PF/2013 (ZIKVAS-FP13) and ZIKVNL00013 (ZIKVAS-Sur16), which
were isolated in 2013 and 2016, respectively, and passaged 4 times on Vero cells. A
phylogenetic analysis of the complete genome of the selected strains with other ZIKV
genomes shows their positions in the Asian or African lineages (Fig. 1A). There are over
50 amino acid (aa) differences between the African and Asian ZIKV strains that have
previously been described (5). The amino acid differences between the Asian ZIKV
strains were located in the NS1 (R67S; position 863), NS2B (S41T; position 1417), and
NS5 (M60V; position 2634) proteins (Fig. 1B). Of these amino acid differences, the
mutation at position 2634 is only observed in viruses isolated from the recent outbreak
(4, 5, 16). The amino acid difference at position 1417 of ZIKVAS-Sur16 was not present in
the original clinical isolate but was acquired during passaging on Vero cells (17).
Growth curves of Asian and African ZIKV strains on neuronal cells. Growth
curves were determined for ZIKVAS-FP13, ZIKVAS-Sur16, ZIKVAF-MR766, and ZIKVAF-976 by in
vitro infections using low multiplicities of infection (MOI [0.1 and 0.01]) on SK-N-SH cells
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(human neuroblastoma cells), U87-MG cells (human glioblastoma cells), Vero cells, and
hNPCs. Growth curves showed that all cells supported replication of all four ZIKV strains
included, but virus titers were signiﬁcantly lower for both Asian strains compared to
ZIKVAF-MR766 strains on cells of the Vero, SK-N-SH, and U87-MG lines and hNPCs (Fig. 2A
and B). On hNPCs, ZIKVAF-MR766 grew faster to signiﬁcantly higher titers than ZIKVAF-976
(Fig. 2A and B). There were no evident differences in the growth curves between
ZIKVAS-FP13 and ZIKVAS-Sur16.
One-step growth curves of Asian and African ZIKV strains on neuronal cells.
One-step growth curves (OSGCs) were assessed in vitro by using a high MOI (MOI of 10).
Data from OSGC experiments on the different cell lines were used to calculate the
percentage of infection and burst size (progeny virus produced per cell). OSGCs
showed that baseline virus titers were higher for the African ZIKV strains than for the
Asian ZIKV strains, and both African ZIKV strains grew to higher titers on all cells
(Fig. 3A). In all cells, African ZIKV strains infected more cells than the Asian ZIKV strains
(Fig. 3B and D). The numbers of virus particles produced did not differ signiﬁcantly
between the different ZIKV strains. However, there was a trend toward burst size being
higher in SK-N-SH cells (~100 to 400 infectious virus particles/cell) than in Vero cells
(~20 to 40 infectious virus particles/cell), U87-MG cells (~50 to 150 infectious virus
particles/cell), and hNPCs (~40 to 75 infectious virus particles/cell) (Fig. 3C).
Induction of cell death by Asian and African ZIKV strains. The ability of
ZIKVAS-Sur16, ZIKVAS-FP13, and ZIKVAF-MR766 to cause cell death in hNPCs at 24, 48, and
FIG 1 Phylogenetic analysis of ZIKV strains used in this study and genomic organization and
mutations between the Asian lineage ZIKV strains. (A) Nucleotide sequences of representative Zika
virus genomes were analyzed, and a phylogenetic tree was constructed using the PhyML method.
Values at branches show the result of the approximate likelihood ratio; values of 0.70 are not
shown. (B) Genome organization and mutations between Asian lineage H/PF/2013 (ZIKVAS-FP13) and
ZIKVNL00013 (ZIKVAS-Sur16) ZIKV strains.
Different Phenotypes of African and Asian ZIKV Strains
July/August 2017 Volume 2 Issue 4 e00292-17 msphere.asm.org 3
 o
n
 August 20, 2018 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
72 hours postinfection (hpi) was determined after infection with an MOI of 3. Cells were
stained for either ZIKV antigen or terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL [DNA fragmentation]) and measured by ﬂow
cytometry. Uninfected cells and -propiolactone (BPL)-inactivated ZIKVAF-MR766 were
included as controls. In addition, cells were ﬁxed at 48 hpi for immunoﬂuorescent
double staining for ZIKV antigen and TUNEL. A maximum of 12% TUNEL positivity was
observed in BPL control and negative-control cells 72 hpi.
Infection with ZIKVAS-FP13 and ZIKVAS-Sur16 resulted in approximately 20% infection
at 72 hpi, and up to 9% of cells were TUNEL positive, the latter comparable to control
and BPL-treated cells. Immunoﬂuorescent staining revealed that very few TUNEL-
positive cells were ZIKV infected (Fig. 4A and B). In contrast, infection with ZIKVAF-MR766
resulted in 46% infection and 30% TUNEL-positive cells at 72 hpi (Fig. 4A). Immuno-
ﬂuorescent staining revealed that in ZIKVAF-MR766-infected cells, the majority of TUNEL-
positive cells were also infected, indicating that ZIKVAF-MR766 is able to induce cell death
early after infection in hNPCs (Fig. 4B).
DISCUSSION
This study on the in vitro replication of different ZIKV strains shows that African ZIKV
strains replicated more efﬁciently in Vero, human glioblastoma, and human neuroblas-
toma cells and hNPCs than Asian ZIKV strains. In hNPCs, which are considered an
important target cell type for the development of congenital microcephaly, African
ZIKV strains induced cell death early after infection, which was not observed after
infection with Asian ZIKV strains.
FIG 2 Growth curves of ZIKV strains on Vero, SK-N-SH, and U87-MG cells and hNPCs. (A and B) Growth curves of Asian lineage strains
H/PF/2013 (ZIKVAS-FP13 [blue lines]) and ZIKVNL00013 (ZIKVAS-Sur16 [green lines]) and African lineage MR766 (ZIKVAF-MR766 [black lines]) and
976 Uganda (ZIKVAF-976 [red lines]) on Vero, human neuroblastoma (SK-N-SH), and human glioblastoma (U87-MG) cells and human
neuronal progenitor cells (hNPCs) at MOI of 0.1 (A) and 0.01 (B). Data are presented as means with standard deviations from at least 3
independent experiments. Statistical signiﬁcance was calculated using the Student t test in comparison with ZIKVAF-MR766. *, P  0.05; **,
P  0.01; ***, P  0.001; ****, P  0.0001. TCID50, 50% tissue culture infectious dose.
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FIG 3 One-step growth curve (OSGC) kinetics of Asian and African lineage ZIKV strains. (A) OSGCs of Asian lineage strains H/PF/2013 (ZIKVAS-FP13 [blue lines])
and ZIKVNL00013 (ZIKVAS-Sur16 [green lines]) and African lineage MR766 (ZIKVAF-MR766 [black lines]) and 976 Uganda (ZIKVAF-976 [red lines]) on Vero, human
neuroblastoma (SK-N-SH), and human glioblastoma (U87-MG) cells and human neuronal progenitor cells (hNPCs). (B) Percentage of ZIKV infection determined
by immunoﬂuorescent microscopy of two Asian and two African ZIKV strains. (C) Number of infectious viruses produced per cell (burst size) for each virus in
the 4 different cell lines. (D) Representative immunoﬂuorescent images of ZIKV-infected cells stained for ZIKV antigen (green). Magniﬁcation, 200. For panels
A and B, data are presented as means with standard deviations and nonlinear curve ﬁt for at least 3 independent experiments. For panel C, data are presented
as means with standard errors of the means from at least 3 independent experiments. Statistical signiﬁcance was calculated using a one-way ANOVA with
Tukey’s multiple comparisons test for panel A. For panels B and C, the Student t test was used. *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001. TCID50,
50% tissue culture infectious dose.
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Overall there were few phenotypic differences between ZIKVAS-FP13 and ZIKVAS-Sur16.
This suggests that the mutations between these viruses, including position 2634 unique
for ZIKV isolated from this outbreak, does not lead to large phenotypic changes, at least
not in these cell lines. The fact that Vero and SK-N-SH cells permit efﬁcient replication
of Asian ZIKV strains supports the usage of these cells for virus isolation from clinical
samples (18).
The replication kinetics and ability to cause cell death in hNPCs differed substantially
between African and Asian ZIKV strains. Asian ZIKV strains infect and replicate less
efﬁciently in hNPCs than the African ZIKV strains. This “reduced” replication is not an
intrinsic feature of Asian ZIKV strains, since they replicate to high titers in Vero and
SK-N-SH cells. One possible explanation for the increased ability of African ZIKV strains
to infect hNPCs in this study could be that these strains have adapted to neural cells
due to their passage history in mouse brain tissues (18) and that the 4-aa deletion in
the E protein of these viruses contributes to the observed phenotype. However, similar
results—high percentage of infection and induction of cell death in hNPCs—have
been observed with a low-passage-number 1989 African ZIKV strain (ArB41644) (12).
Upon sequencing, we did not ﬁnd any deletion in the E protein (GenBank accession no.
KY576904) of this low-passage-number African lineage ZIKV strain. Therefore, these
studies together suggest that Asian ZIKV strains infect hNPCs less efﬁciently than
African ZIKV strains, regardless of the passage history of the ZIKV strains. Both Asian
lineage ZIKV strains do not seem to induce cell death early after infection, whereas
ZIKVAF-MR766 does. This ﬁts with previous observations, where more apoptotic nuclei
were observed after infection with an African ZIKV strain than with an Asian ZIKV strain
(12), which suggests that there are intrinsic differences between Asian and African ZIKV
strains in their ability to cause cell death in hNPCs.
The observed phenotypic characteristics of Asian lineage ZIKV strains might con-
tribute to their ability to cause chronic infection in tissues of the CNS (17–21). First,
Asian ZIKV strains infect relatively few hNPCs. Second, Asian ZIKV strains release less
FIG 4 Ability to cause cell death of African and Asian lineage ZIKV strains in human neural progenitor cells. (A) Percentage
of human neural progenitor cells infected with African lineage ZIKV strain ZIKVAF-MR766 (black lines) and Asian lineage ZIKV
strains H/PF/2013 (ZIKVAS-FP13 [blue lines]) and ZIKVNL00013 (ZIKVAS-Sur16 [green lines]) and percentage of TUNEL-positive cells
measured over 72 h. The left y axis represents the percentage of cells infected with ZIKV, and the right y axis represents the
percentage of TUNEL-positive cells. Data are presented as means with standard errors of the means from at least 3
independent experiments. (B) Representative immunoﬂuorescent images of human neural progenitor cells infected with
different ZIKV strains 48 h postinfection and double stained for ZIKV antigen (red) and TUNEL (green). Asterisks indicate
double-positive cells. Magniﬁcation, 200.
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than 40 infectious virus particles per infected hNPC, which is relatively low compared
to other viruses, such as inﬂuenza virus and simian immunodeﬁciency virus (SIV) (22,
23). A low burst size has previously also been associated with prolonged virus replica-
tion within the CNS for Japanese encephalitis virus, another ﬂavivirus (24). Finally, Asian
ZIKV strains do not seem to induce cell death early after infection in neural progenitor
cells, which might result in chronic infection and replication within the CNS (19, 20).
This ﬁts with a recent animal study using Stat2/ mice, which showed that African
ZIKV strains induce short episodes of severe neurological symptoms followed by
lethality, while Asian ZIKV strains manifest prolonged signs of neuronal malfunctions.
Limited mortality was also only observed in one Asian ZIKV strain (25).
Taken together, we here show that African and Asian ZIKV strains differ in their
abilities to infect and replicate in different neural cells, as well as their abilities to cause
cell death early after infection. This implies that caution is necessary against extrapo-
lation of experimental data obtained using historical African ZIKV strains to the current
outbreak. In addition, the fact that Asian ZIKV strains infect only a minority of cells with
a relatively low burst size together with the lack of early cell death induction might
contribute to their ability to cause chronic infections within the CNS.
MATERIALS AND METHODS
Cells. Human induced pluripotent stem cell (IPSC)-derived neural progenitor cells (NPCs) (Ax0015;
Axol, Cambridge, United Kingdom) were cultured in neural maintenance basal medium with supple-
ments (Ax0031; Axol) according to the manufacturer’s speciﬁcation. Human IPSC-derived NPCs were
grown on plates coated with 20 g/ml laminin (L2020; Sigma-Aldrich). Human neuroblastoma SK-N-SH
and human glioblastoma U87-MG cells were purchased from Sigma-Aldrich and grown in Eagle’s
minimum essential medium (EMEM) with Earle’s balanced salt solution (EBSS [Lonza, Breda, The Neth-
erlands) containing 10% heat-inactivated fetal bovine serum (HI-FBS [Lonza]), 100 U penicillin (Gibco Life
Sciences, USA), 100 g/ml streptomycin (Gibco), 2 mM L-glutamine (Lonza), 1% nonessential amino acids
(Lonza), 1 mM sodium pyruvate (Gibco), and 1.5 mg/ml sodium bicarbonate (Lonza). Both immortalized
cell lines SK-N-SH and U87-MG were used below passage 25. Vero cells (ATCC, USA) were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 10% HI-FBS, 100 g/ml streptomycin, 100 U
penicillin, 2 mM L-glutamine, 1% sodium bicarbonate, and 1% HEPES buffer (all from Gibco). Human NPCs
are primary cells, while the other cells are from immortalized cell lines. All cells used in this study tested
negative for Mycoplasma sp.
Viruses. Zika virus strain Uganda 976 (ZIKVAF-976) was provided by Misa Korva (University of Ljubljana;
European Virus Archive goes Global [EVAg] no. 007V-EVAg1585). Zika virus MR766 (ZIKVAF-MR766) was
provided by Stephan Günther (Bernhard-Nocht-Istitute for Tropical Medicine). This strain has three
nucleotides different (C6258T, G6273T, and G10671A) from the reference MR766 strain (GenBank
accession no. KU955594). Zika virus strain H/PF/2013 (ZIKVAS-FP13) was obtained from UMR 190-Unite Des
Virus Emergents (EVAg no. 001V-EVA1545). Zika virus Suriname ZIKVNL00013 (ZIKVAS-Sur16) was isolated
from a patient in The Netherlands (EVAg no. 011V-01621) (17). All virus stocks used in this study were
grown in Vero cells. The following passage numbers were used: passage 6 (P6) for ZIKVAF-976, unknown
for ZIKVAF-MR766, and P4 for ZIKVAS-FP13 and ZIKVAS-Sur16. Virus titers were determined in Vero cells 5 days
after infection by means of cytopathic effect (CPE), and the 50% tissue culture infective dose (TCID50) was
calculated using the Spearman-Kärber method (26). All virus stocks were stored at 80°C until further
use. A summary of the isolation history of all ZIKV strains used in this study and related information is
provided in Table 1.
Next-generation sequencing. For genomic characterization of the virus strains, RNA was isolated
from 140 l of the virus stocks with the QIAmp Viral Mini RNA kit (Qiagen, Germany). Subsequently, the
product was eluted in 40 l double-distilled water. Viral metagenomic libraries were constructed with
TABLE 1 Source host, isolation, and passage history as well as GenBank accession numbers of the ZIKV strains used in the studya
Lineage Strain
Source
host
Yr of
isolation Location Passage history
GenBank
accession no. EVAg no.
Asian ZIKVNL00013 Human 2016 Suriname 4 on Vero cells KU937936 011V-01621
H/PF/2013 Human 2013 French Polynesia 4 on Vero cells KJ776791.2 001V-EVA1545
African MR766 Monkey 1947 Uganda Unknown (multiple times on SMB and 1
on Vero cells)
KU955594 NA
Uganda 976 Monkey 1961 Uganda 2 on SMB, 3 on Vero E6 cells, 1 on
Vero cells
NA 007V-EVAg1585
aAbbreviations: SMB, suckling mouse brain; Vero, African green monkey kidney cells; Vero E6, African green monkey kidney clone E6 cells; EVAg, European Virus
Archive goes Global; NA, not available.
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454 pyrosequencing as previously described (27), and the libraries were sequenced using a 454 GS-Junior
machine (Roche, USA) according to the manufacturer’s instructions.
Phylogenetic analysis. Nearly full-length ZIKV genomes of 4 isolates (ZIKVAF-976, ZIKVAF-MR766,
ZIKVAS-FP13, and ZIKVAS-Sur16) and other reference sequences were obtained from the GenBank database.
The sequences were aligned using ClustalW, and a phylogenetic tree was constructed by using the
PhyML method in SeaView 4 (http://pbil.univ-lyon1.fr/software/seaview) with the approximate likelihood
ratio test based on a Shimodaira-Hasegawa-like procedure which used general time reversible as a
substitution model. Nearest-neighbor interchange, subtree pruning, and regrafting-based tree search
algorithms were used to estimate tree topologies (28). The obtained tree was visualized by using FigTree
version 1.3.1 (http://tree.bio.ed.ac.uk/software/ﬁgtree).
Replication kinetics of Zika virus strains. Replication kinetics of ZIKV strains ZIKVAS-976, ZIKVAS-MR766,
ZIKVAS-FP13, and ZIKVAS-Sur16 were studied in vitro by means of one-step growth curve (OSGC) experiments
with a multiplicity of infection (MOI) of 10 and focal experiments (growth curves) with MOI of 0.1 and
0.01. Human neural progenitor cells and SK-N-SH, U87MG, and Vero cells were seeded into 96-well plates
(2  104 cells) (Greiner, USA). After 24 h, monolayers were inoculated with the different ZIKV strains or
Vero cell culture medium as a control at an MOI of 10, 0.1, or 0.01 for 1 h at 37°C in 5% CO2. After 1 h
of virus absorption, the inoculum was removed and cells were washed 3 times and replenished with fresh
medium that contains 2% FCS (no FCS for hNPCs) and cultured for 24 or 72 h at 37°C for the OSGC and
growth curve, respectively. For the OSGC, supernatant was collected every 2 h up to 24 h and
subsequently stored at 80°C until virus titer determination. Cells were ﬁxed in 4% paraformaldehyde
(PFA) for 20 min at room temperature, washed with phosphate-buffered saline (PBS), and permeabilized
and stored in 70% ethanol for immunoﬂuorescent staining. For the growth curves, supernatant was
collected at time points 0, 1, 12, 24, 48, and 72 hpi and stored at 80 until use. All growth curves and
OSGCs were performed 3 times (biological replicates), and each growth curve included duplicate
(technical replicates) measurements from which the average was used for future analysis.
Determination of virus titers. Virus titers (TCID50) in the supernatant were determined by endpoint
titrations on Vero cells. Tenfold serial dilutions were made and inoculated onto a monolayer of Vero cells.
Cytopathic effect (CPE) was determined at 5 days postinfection (dpi), and virus titers were calculated
using the Spearman-Kärber method (26). An initial 1:10 dilution of supernatant resulted in a detection
limit of 101.5 TCID50/ml.
Immunoﬂuorescence microscopy. Infected cells from the OSGC at the time when 50% of virus
particles are released (BT50) were ﬁxed with 4% PFA for 20 min at room temperature, washed, and
permeabilized with 70% ethanol. Subsequently, cells were washed twice in PBS and incubated for 1 h in
the dark and at room temperature with anti-Flavivirus group antigen (MAB10216, clone D1-4G2-4-15,
1:200 dilution; Millipore, Germany) or mouse IgG2a isotype control (MAB003, 1:50 dilution; R&D Systems)
in PBS containing 0.1% bovine serum albumin (BSA). Afterward, the cells were washed three times with
PBS–0.1% BSA and incubated for 1 h with goat anti-mouse IgG2a conjugated with Alexa Fluor 488 (1:250
dilution; Life Technologies, Inc., The Netherlands) in PBS–0.1% BSA at room temperature and in the dark.
After 1 h, cells were washed three times and mounted with ProLong Diamond Antifade mountant with
DAPI (4=,6-diamidino-2-phenylindole [Life Technologies, Inc., USA]). Zika virus-infected cells were iden-
tiﬁed by use of a Zeiss LSM 700 confocal laser scanning microscope ﬁtted on an Axio observer Z1
inverted microscope (Zeiss). All images were processed using Zen 2010 software (Zeiss). Per sample, 5
high-power ﬁelds were photographed and scored blindly by three individuals to determine the per-
centages of infected and noninfected cells.
Calculation of percentage of infection and burst size. The percentage of infection and burst size
were calculated from the OSGC experiment. The burst size is deﬁned as the number of progeny virus
particles produced per infected cell and was calculated as follows. The time at which half the number of
progeny virus were released into the supernatant (50% effective concentration [EC50] for dose-response
curve) was determined, which was calculated by using a nonlinear regression analysis (sigmoidal
dose-response, variable slope) in GraphPad Prism 6.0h using the infectious virus titer data from the OSGC
measured over 24 h (2-h increments). At this time point, infected cells were ﬁxed and stained for ZIKV
(as described above), and the number of infected cells was calculated by counting virus-infected/
uninfected cells in 5 randomly chosen panels in duplicate by 3 blind assessors. The average number of
infected cells from 5 panels was taken and corrected for the surface area of a single 96-well ﬂat bottom
plate. Next, the infectious virus titer over 24 h was calculated by subtracting time point 0 from 24 h,
which then was divided by the number of infected cells, resulting in the number of progeny virus
particles produced per infected cell.
TUNEL assay. Human neural progenitor cells (hNPCs) were cultured in a 24-well plate and inoculated
with ZIKVAS-MR766, ZIKVAS-FP13, or ZIKVAS-Sur16 at an MOI of 3. In addition, ZIKVAS-MR766 was inactivated using
-propiolactone (BPL) (1:4,000 vol/vol; Sigma-Aldrich, USA) at 4°C for 48 to 72 h. Subsequently, BPL was
inactivated for 24 h at 37°C. Both inactivated ZIKVAS-MR766 and Vero cell culture supernatant served as
negative controls. Viruses and controls were allowed to absorb for 1 h, after which hNPCs were washed
three times in hNPC medium. Subsequently the medium was replenished with fresh medium and
cultured at 37°C for 24, 48, or 72 h. The numbers of dead cells were measured with a Sigma-Aldrich In
situ cell death detection kit with ﬂuorescein (Sigma-Aldrich, USA). Brieﬂy, the cells were ﬁrst ﬁxed with
4% PFA and permeabilized with a 1:1 dilution of 1% Triton X-100 and 70% ethanol. Noninfected cells
were treated with 180 IU/ml DNase (Roche Diagnostics, Mannheim, Germany) for 15 min at room
temperature to serve as a positive control. The In situ cell death detection kit with ﬂuorescein was used
according to the manufacturer’s instructions. Cells stained only with labeling solution were used as a
negative control as suggested by the manufacturer. The number of TUNEL-positive cells was measured
Anfasa et al.
July/August 2017 Volume 2 Issue 4 e00292-17 msphere.asm.org 8
 o
n
 August 20, 2018 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
using a BD FACSCanto II (BD Biosciences, USA). Data were analyzed using FlowJo 10 software (Ashland,
OR, USA). All experiments were performed three times (biological replicates), and each experiment
included duplicate (technical replicate) measurements from which the average was calculated and used
for further analysis.
Flow cytometry assay. Cells were infected the same way as described for the TUNEL assay. At time
points 24, 48, and 72 h, cells were collected, ﬁxed, and permeabilized using BD Cytoﬁx/Cytoperm solution
(BD Biosciences, USA) according to the manufacturer’s instructions. Cells were blocked using 10% normal
goat serum (NGS [Dako, Denmark]) for 10 min on ice. Subsequently, Zika virus was detected using mouse
monoclonal antibody against anti-ﬂavivirus group antigen (MAB10216, clone D1-4G2-4-15; Millipore,
Germany) at a 1:200 dilution or mouse IgG2a isotype control (MAB003; Dako, Denmark) at a 1:50 dilution
in BD Perm/Wash containing 2% NGS and incubated for 1 h on ice and in the dark. Cells were washed
twice, and goat anti-mouse IgG2a conjugated with Alexa Fluor 488 (Life Technologies, Inc., The
Netherlands) at a 1:250 dilution was incubated for 1 h in the dark and on ice. After incubation of the
secondary antibody, cells were washed twice and resuspended in ﬂuorescence-activated cell sorter
(FACS) buffer. The percentage of infected cells was measured using a BD FACSCanto II (BD Biosciences,
USA). Data were analyzed using FlowJo 10 software (Ashland, OR, USA). All experiments were performed
three times (biological replicates), and each experiment included duplicate (technical replicate) mea-
surements from which the average was calculated and used for further analysis.
Statistical analysis. The statistical analyses were performed using GraphPad Prism 6.0h software (La
Jolla, CA) for Mac. Student’s t test was used for comparison between two groups. For comparison
between multiple groups, one-way analysis of variance (ANOVA) with Tukey’s multiple-comparison test
was used. P values of 0.05 were considered signiﬁcant.
Accession number(s). Sequences of the E protein from African ZIKV strain ArB41644 have been
submitted to GenBank under accession no. KY576904.
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